title: The insulin resistance-dyslipidemic syndrome: contribution of visceral obesity and therapeutic implications.
authors.affiliation: Lipid Research Center, CHUL Research Center, Ste-Foy, Canada.
authors.forename: J P
authors.initials: JP
authors.lastname: Després
authors.forename: S
authors.initials: S
authors.lastname: Lemieux
authors.forename: B
authors.initials: B
authors.lastname: Lamarche
authors.forename: D
authors.initials: D
authors.lastname: Prud'homme
authors.forename: S
authors.initials: S
authors.lastname: Moorjani
authors.forename: L D
authors.initials: LD
authors.lastname: Brun
authors.forename: C
authors.initials: C
authors.lastname: Gagné
authors.forename: P J
authors.initials: PJ
authors.lastname: Lupien
mesh_terms: D000273:Adipose Tissue / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D002318:Cardiovascular Diseases / Q000209:etiology / Q000235:genetics / Q000503:physiopathology; D005277:Fenfluramine / Q000627:therapeutic use; D006801:Humans; D006949:Hyperlipidemias / Q000150:complications* / Q000235:genetics / Q000503:physiopathology; D007333:Insulin Resistance / Q000235:genetics / Q000502:physiology*; D009765:Obesity / Q000150:complications* / Q000188:drug therapy / Q000235:genetics; D012307:Risk Factors; D013577:Syndrome
chemical_list: D005277:Fenfluramine